Cost per beneficiary of select drugs in Canada's public drug plans 2017-2018

As of fiscal year 2017/2018, prescription drug Janumet (with the ingredients sitagliptin and metformin) cost, on average, about 968 Canadian dollars per beneficiary. Janumet is a widely used medicine to treat type 2 diabetes.

Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2017/2018 (in Canadian dollars)*

Average cost in Canadian dollars per prescription
Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date




Survey time period

FY 2017/2018

Supplementary notes

* The public drug plans include British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and the Non-Insured Health Benefits Program.
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Canadian pharmaceutical industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.